Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fulvi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medicina (Florence, Italy)|October 1, 1988
[Calcium antagonists]D Bracchetti, M Fulvi
Giornale Italiano Di Cardiologia|November 1, 1988
[Calcium antagonists in angina pectoris]D Bracchetti, P Sangiorgio, M Fulvi, et al.
Giornale Italiano Di Cardiologia|May 1, 1989
[Paroxysmal tachycardia with long QRS (left branch block type) in a female patient with accessory nodo-ventricular pathway. Role of the anomalous pathway in the electrogenesis of the arrhythmia]R F Guaragna, M Palmieri, M Fulvi, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Long-term treatment after acute myocardial infarction: antiarrhythmic therapy and prophylaxis. Which drug for which patient?D Bracchetti, F Naccarella, M Palmieri, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medicina (Florence, Italy)|October 1, 1988
[Calcium antagonists]D Bracchetti, M Fulvi
Giornale Italiano Di Cardiologia|November 1, 1988
[Calcium antagonists in angina pectoris]D Bracchetti, P Sangiorgio, M Fulvi, et al.
Giornale Italiano Di Cardiologia|May 1, 1989
[Paroxysmal tachycardia with long QRS (left branch block type) in a female patient with accessory nodo-ventricular pathway. Role of the anomalous pathway in the electrogenesis of the arrhythmia]R F Guaragna, M Palmieri, M Fulvi, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Long-term treatment after acute myocardial infarction: antiarrhythmic therapy and prophylaxis. Which drug for which patient?D Bracchetti, F Naccarella, M Palmieri, et al.
Pageof 1